Study of vitiligo at a tertiary care hospital

 

 

REFERENCES

1. Guerra L, Dellambra E, Brescia S, Raskovic D (2010) Vitiligo: pathogenetic hypotheses and targets for current therapies. Curr Drug Metab 11(5): 451-467.
2. Alikhan A, Felsten LM, Daly M, Petronic‑Rosic V. Vitiligo: A comprehensive overview part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work‑up. J Am Acad Dermatol 2011;65:473‑91.
3. Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol 2012;51:1206‑12.
4. Shah H, Mehta A, Astik B (2008) Clinical and sociodemographic study of vitiligo. Indian J Dermatol Venereol Leprol 74(6): 701.
5. Kutlubay Z, Karakus O, Engin B, Serdaroglu S. Vitiligo as an autoimmune disease. J Turk Acad Dermatol 2012;6:1262.
6. Kostovic K, Pasic A. New treatment modalities for vitiligo: Focus on topical immunomodulators. Drugs 2005;65:447‑59.
7. Behl PN, Agarval A, Srivastava G. Etiopathogenesis of vitiligo: Are we dealing with an environmental disorder? Indian J Dermatol Venereol Leprol 1999;65:161‑7.
8. Jeon IK, Park CJ, Lee MH, Lee DY, Kang HY, Hann SK, et al. A multicenter collaborative study by the Korean society of vitiligo about patients’ occupations and the provoking factors of vitiligo. Ann Dermatol 2014;26:349‑56.Kar PK. Vitiligo: A study of 120 cases. Indian J Dermatol Venereol Leprol 2001;67:302-4.
9. Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol 2012;51:1206‑12.
10. Shah H, Mehta A, Astik B. Clinical and sociodemographic study of vitiligo. Indian J Dermatol Venereol Leprol 2008;74:701.
11. Shajil EM, Agrawal D, Vagadia K, Marfatia YS, Begum R. Vitiligo: Clinical profiles in Vadodara, Gujarat. Indian J Dermatol 2006;51:100-4.
12. Shankar DS, Shashikala K, Madala R. Clinical patterns of vitiligo and its associated co morbidities: A prospective controlled cross-sectional study in South India. Indian Dermatol Online J 2012;3:114-8.
13. Misri R, Khopkar U, Shankarkumar U, Ghosh K. Comparative case control study of clinical features and human leukocyte antigen susceptibility between familial and nonfamilial vitiligo. Indian J Dermatol Venereol Leprol 2009;75:583-7.
14. Alissa A, Al Eisa A, Huma R, Mulekar S. Vitiligo-epidemiological study of 4134 patients at the National Center for Vitiligo and Psoriasis in Central Saudi Arabia. Saudi Med J 2011;32:1291-6.
15. Shankar DS, Shashikala K, Madala R. Clinical patterns of vitiligo and its associated co morbidities: A prospective controlled cross-sectional study in South India. Indian Dermatol Online J 2012;3:114-8.
16. Pasricha JS, Khaitan BK, Dash S. Pigmentary disorders in India. Dermatol Clin 2007;25:343-52.